Devon Womack
President
As we reflect on the past year, it’s clear that meaningful change doesn’t happen in isolation. It grows from shared commitment, collective effort, and the relationships we nurture along the way. Progress this year came through collaboration—working side by side with practices in The Network to create solutions that make a lasting difference for providers and the patients they care for. We focused on building connections and laying the foundation for sustainable growth, to continue delivering exceptional care close to home well into the future. Through thoughtful partnerships and innovative approaches, The Network is positioning itself to meet the needs of tomorrow.
The Network Today: Strength and Momentum
This year, our footprint continued to grow by welcoming Florida Cancer Specialists & Research Institute along with a number of new practices that joined current partners like Millenium Physicians (Texas Oncology), ChristianaCare (Medical Oncology Hematology Consultants), and Colon and Rectal Surgical Associates (Minnesota Oncology). We also renewed our agreement with Southern Cancer Center, reinforcing our shared commitment to community oncology.
Through these new practices and strategic recruiting efforts for other practices, we welcomed over 900 new providers to existing practices in The Network—expanding expertise and strengthening care teams to meet the evolving needs of patients and communities.
This scale matters because it highlights our national reach and the ability to keep care close to home for patients while providing strong support for practices. Behind these numbers are real results that amplify the collaborative efforts, the strength, and the momentum of The Network and the impact we are making together.
Here are a few highlights from 2025:
- Accelerate: In early November, we joined 1,500 other physicians, clinicians, practice leaders, and industry experts in Las Vegas for the inaugural McKesson event to ignite the future of community oncology.
- Clinical Research: Our partnership with SCRI boosted trial enrollment by 33%, which not only improves patient access to cutting-edge clinical therapies but also can help achieve better outcomes.
- Technology: Over 1,000 providers have leveraged DeepScribe AI for ambient AI noting, saving on average 2-3 hours per week, helping to reduce provider burnout.
- Patient Experience: Across The Network, patient access has increased, leading to a 70% reduction in patient wait times across our practices.
- Value-Based Care: Through the Enhancing Oncology Model (EOM) performance periods 1 & 2, our efforts delivered $88 million in gross savings for Medicare compared to benchmark, with Network practices representing over 50% of patients, reinforcing our commitment to leadership in high-quality, cost-effective care.
- Advanced Therapies: We are bringing next-generation cancer care into community settings through bold investments, practice-led resources, and integrated surgical partnerships that create true centers of excellence. All practices in The Network support bispecific therapies, with several offering options for CAR-T, and over half of our practices providing radiopharmaceutical treatment options to patients.
- Public Policy: Physician-led engagements, such as congressional fly-ins and targeted Capitol Hill visits, actively lobbied Congress to advance site-neutral reimbursement policies, ensuring community oncology practices receive equitable payments regardless of care setting, and influenced other issues, including telehealth access, prior authorization reform, and cancer screening policies.
- Precision Medicine: Through the Precision Care Companion program, 12 practices across The Network are advancing personalized cancer care in the community. This initiative integrates education, clinical support, technology, data analytics, and best practices to bring precision oncology closer to home for patients.
However, when we talk about growth and momentum, it’s not just numbers – growth means something deeper.
Investing in Practices
In 2025, we committed over $114 million in capital investments to strengthen practices and expand access to care. From modernized patient facilities at Virginia Cancer Specialists, to expanded service lines at Maryland Oncology Hematology that bring more services closer to home for patients, and new spaces for advanced therapies at Compass Oncology and Texas Oncology —these investments reflect our commitment to keeping cancer care local, accessible, and ready for the future.
Maryland Oncology Hematology, Compass Oncology, Virginia Cancer Specialists, Texas Oncology
Meeting modern-day oncology challenges head-on demands a strategic partnership, scalable infrastructure, and innovation that works in the real world.
Looking Forward
The future of The Network is being shaped every day—through decisions, pilots, and conversations that reflect the shared commitment of our partners. Together, we are defining what success looks like and co-creating the next chapter of cancer care.
As we move forward, we’ll continue building this momentum—exploring new ideas, strengthening partnerships, and finding innovative ways to support practices and patients. We’re proud to navigate the future together. Because excellence in cancer care has a network.
By Devon Womack, president
As we wrap up 2024, I’m honored to reflect on the year that The US Oncology Network has had and the impact we’ve made in bringing the most effective and innovative cancer care to patients in their local communities.
Advancing our mission
In 2024, we welcomed Tennessee Cancer Specialists and Illinois CancerCare to The Network. By adding these practices to our organization, we are fortified by new ideas and new best practices, ensuring community care remains strong.
We also added over 60 physicians to existing practices in The Network, showing that we are delivering on our commitment of being a best place to work.
Finally, I’m thrilled we renewed our agreement with Rocky Mountain Cancer Centers. We are only as strong as the practices in our network, and this renewal solidified our combined strength.
Innovating for tomorrow
An area where we are differentiating ourselves is in innovation – we’re keeping an eye toward the future and making sure that we are well-positioned to offer the very best to patients.
Our collaboration with Sarah Cannon Research Institute is compelling – creating tremendous momentum in enrolling patients in trials that will bring new therapies to the market. We enrolled over 1,200 patients this year, and I’m excited to see this number grow in the new year.
With precision medicine at the forefront of cancer care, The Network is focused on increasing biomarker testing by alleviating the burden of test ordering, delivering molecular results directly into the EHR, and providing a variety of educational opportunities on the latest in precision medicine.
Putting patients at the center
We remain committed to delivering value to patients – and one way this is evident is through the increased use of Findhelp, the platform that assists in navigating social services, community resources, and referrals for patients. This year, practices in The Network referred more than 4,000 patients to community-based social services, showing our dedication to the whole patient beyond solely a cancer diagnosis.
We’ve also continued to demonstrate leadership in value-based care initiatives like the Enhancing Oncology Model, where we have 12 practices and over 1,500 providers participating. Practices in The Network make up almost 50% of the participants in the EOM.
Powering our network
At the core of The Network is the providers and staff in the practices each day, connecting with patients and thinking about how we can continue to bring the best care to communities. One of the greatest assets we can offer to practices in The Network is the opportunity to connect with others to share learnings and resources. Next year, I hope you’ll join us at McKesson Accelerate, where we’re building on The Network’s Annual Conference and creating a premier conference designed exclusively for community oncology practices. We hope to see you there!
Devon Womack
President
By The Network’s editorial staff
As cancer care evolves at an increasingly rapid pace, The US Oncology Network stands at the forefront of community oncology, dedicated to advancing care and enhancing patient outcomes. Leading this charge is our new president Devon Dickey Womack, whose appointment marks a significant milestone in our journey towards setting new standards in oncology care. With an unwavering commitment and a visionary approach, she is poised to steer The Network through its next phase of growth and innovation, ensuring that we support practices as they continue to deliver best-in-class care.
With a 14-year tenure with The Network and McKesson, Devon is a familiar face and brings deep expertise and dynamic leadership to her new role. Most recently as the chief operating officer of The Network, she made great strides in ensuring practices have the resources they need to operate efficiently and deliver cost-effective, high-quality patient care. She led the launch of The Network’s “Time to First” strategy to improve patient access. Through this initiative, more than 70% of practices in The Network reduced the time for patients to complete their first consult with their oncologist.
Additionally, Devon continues to pave the way for research expansion with eleven practices in The Network entering into new research agreements with Sarah Cannon Research Institute (SCRI). We are already exceeding our initial treatment trial accruals goal, starting the fiscal year off strong. Our goal is to ensure that more patients have access to modern cancer therapies and treatment trials. Advancing cancer research to make these therapies a reality for everyone happens in the community setting.
Devon is deeply committed to the development and support of oncology practices and their ability to deliver top-tier care, aiming to support more than 25% of cancer patients across the nation. Under her leadership, The Network is continuing to double down on its focus on patient care models that encompass not only state-of-the-art treatments but also psychological and social support for patients and their families.
As she takes the helm of The Network, Devon is enthusiastic about the potential for transformative change in community oncology. Her vision encompasses a broad spectrum of initiatives aimed at enhancing patient care through technological innovation, precision medicine, operational excellence and practice growth.
“There is much to be optimistic about in the future of community oncology. Our commitment lies in providing cutting-edge care, right in your own backyard,” says Devon. “Together, we will ensure that patients receive world-class treatment, while fostering an environment where practices, physicians and care teams can thrive and make a lasting impact on their communities.”
As we embark on this exciting new chapter under Devon’s leadership, The Network is positioned not only to meet the current demands of oncology care but to anticipate and respond to future challenges. Her strategic vision, coupled with a relentless dedication to excellence, will guide The Network as the leader in community oncology, setting the standard for care, compassion and innovation.
By Marcus Neubauer, MD, Chief Medical Officer
The Network was thrilled to host another installment of our Annual Conference last month in Indianapolis. It’s always hard to top the previous year, but we just may have on the heels of tremendous growth of The Network and the excitement for what we are accomplishing together.
The Annual Conference is our signature event, and we were honored to host leaders from practices in The Network as we came together to hear insights on trends in oncology and network with our peers. I feel more energized than ever after the conclusion of the event and know that many who attended feel the same way. The power of The Network was palpable!
Here are a few of my takeaways from this year’s Annual Conference:
The tenacity and ingenuity of practices in The Network is remarkable
The theme of this year’s conference was “the power of community in action” – and I heard countless examples of how practices in The Network are living this every day. When a challenge is identified with the patient experience or clinic workflows, we work together to develop innovative and enduring solutions.
A great example was one that Jason Hammonds shared in his opening session: an initiative at Texas Oncology to redefine how the practice engages with new and existing patients. It is called “Project Touchpoint” and it is a first-of-its-kind, customized platform that uses AI-generated phone triage to capture incoming calls and solve for the issue on the first call. This has shown to significantly reduce unanswered calls.
Across The Network, the patient experience is at the core of innovation and Devon Womack spoke in her session about the investments we are making in this area. Devon reported on a Network-wide initiative to reduce the time to schedule new cancer patients.
We are making tremendous strides in advancing therapies for patients through research
We recently marked the first full year of our joint venture with Sarah Cannon Research Institute (SCRI), a partnership that is elevating clinical cancer research and advancing therapies available for patients. At the Annual Conference, we heard through a panel presentation that more trials are now available to practices in The Network and time to open a trial is much faster with SCRI. This leads to more clinical trial opportunities for patients.
In addition, Genospace is helping practices in The Network solve one of the most complex challenges in research – identifying eligible patients. Among Genospace’s many functions is the ability to connect biomarker test results with each practice’s clinical data from their electronic health record. This provides advanced clinical trial matching and we’re already seeing practices realize the results of leveraging this technology. We will continue to see more synergies with SCRI and more benefits to the patient as time progresses.
Our focus on precision medicine is ensuring patients receive the most effective treatment possible
In The Network, we’ve been developing a cutting-edge precision medicine program that supports practices in ordering biomarker tests and the use of targeted therapies. Trends presented at the Annual Conference show that this program is taking off.
The team has focused their efforts in three areas: education, workflow and technology. Spanning these areas is the implementation of a genomic ordering module within iKnowMed℠, our oncology electronic health record, to provide practices with National Comprehensive Cancer Network® (NCCN®) testing alerts at the time of diagnosis and staging. The team is also utilizing Genospace for automated biomarker result integration and is continuing to build out the shared capabilities between our organizations. This work is ensuring more patients are receiving the most effective treatments.
While I’ve shared three takeaways here, we discussed a number of other topics at the Annual Conference, including value-based care, public policy, best practices and more. The expertise and the passion in The Network is unmatched and it’s wonderful to be reminded of our collective power when we come together!
Marcus Neubauer, MD
Chief Medical Officer
